Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil for overactive bladder urodynamic assessment
2006-005145-11Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in overactive bladder (OAB) and cystospasm comparing Vardenafil with Placebo (2 arms). Primary endpoints: Change from baseline in bladder volume at first detrusor contraction and Change in number of daily micturitions. Started May 2007; status: completed.
02
Drugs
vardenafil
03
Conditions
overactive bladder (OAB)cystospasm
Beyond the preview
Go deeper on 2006-005145-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005145-11.